I gave those first figures in your rapid-fire approach here, which I very much appreciate, on the National Research Universal reactor and medical isotopes. We're taking action here to ensure security and diversity of supply by investing more than $60 million in alternative technologies to diversify sources of supply. This would come through the isotope technology acceleration program—I think ITAP is its acronym—investing in three projects led by innovative Canadian organizations. We're also active in internationally encouraging a better coordination of world supply and the efficient use of medical isotopes, which is often the biggest concern in this discussion.
We note, then, that before 2010 the NRU produced more than 40% of the global supply. Today those supplies are between 15% to 20%.